Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 84.03M | £ 73.20M | £ 97.06M | £ 80.60M | £ 86.38M |
Total Assets | £ 165.48M | £ 145.14M | £ 162.14M | £ 149.54M | £ 141.34M |
Total Debt | £ 13.96M | £ 14.72M | £ 15.59M | £ 15.70M | £ 16.34M |
Net Debt | £ -70.07M | £ -58.49M | £ -81.47M | £ -64.90M | £ -70.04M |
Total Liabilities | £ 32.09M | £ 29.29M | £ 31.43M | £ 31.59M | £ 31.87M |
Stockholders Equity | £ 133.39M | £ 115.85M | £ 130.71M | £ 117.94M | £ 109.47M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |